Platelet-Derived Growth Factors from a Single Donor by Apheresis and One Freeze–Thaw Cycle for Treating Medication-Related Osteonecrosis of the Jaw

References

• ChienHI , ChenLW , LiuWCet al.Bisphosphonate-related osteonecrosis of the jaw. Ann. Plast. Surg.86(25), S78–S83 (2021).
   PubMedGoogle Scholar
• MarinoS , PetruscaDN , RoodmanGD. Therapeutic targets in myeloma bone disease. Br. J. Pharmacol.178(9), 1907–1922 (2021).
   PubMed Web of Science ®Google Scholar
• GozzettiA , GennariL , MerlottiDet al.The effects of zoledronic acid on serum lipids in multiple myeloma patients. Calcif. Tissue. Int.82(4), 258–262 (2008).
   PubMed Web of Science ®Google Scholar
• StellerD , HerbstN , PriesR , JuhlD , HakimSG. Impact of incubation method on the release of growth factors in non-Ca2+-activated PRP, Ca2+-activated PRP, PRF and A-PRF. J. Craniomaxillofac. Surg.47(2), 365–372 (2019).
   PubMed Web of Science ®Google Scholar
• InchingoloF , CantoreS , DipalmaGet al.Platelet rich fibrin in the management of medication-related osteonecrosis of the jaw: a clinical and histopathological evaluation. J. Biol. Regul. Homeost. Agents.31(3), 811–816 (2017).
   PubMed Web of Science ®Google Scholar
• Lopez-JornetP , SanchezPerez A , AmaralMendes Ret al.Medication-related osteonecrosis of the jaw: is autologous platelet concentrate application effective for prevention and treatment? A systematic review. J. Craniomaxillofac. Surg.44(8), 1067–1072 (2016).
   PubMed Web of Science ®Google Scholar
• GhanaatiS , Herrera-VizcainoC , Al-MaawiSet al.Fifteen years of platelet rich fibrin in dentistry and oromaxillofacial surgery: how high is the level of scientific evidence?J. Oral. Implantol.44(6), 471–492 (2018).
   PubMed Web of Science ®Google Scholar
• FornainiC , CellaL , OppiciAet al.Laser and platelet-rich plasma to treat medication-related osteonecrosis of the jaws (MRONJ): a case report. Laser Ther.26(3), 223–227 (2017).
   PubMedGoogle Scholar
• MauceriR , PanzarellaV , ManiscalcoLet al.Conservative surgical treatment of bisphosphonate-related osteonecrosis of the jaw with Er,Cr:YSGG laser and platelet-rich plasma: a longitudinal study. Biomed. Res. Int.2018, 3982540 (2018).
   PubMed Web of Science ®Google Scholar
• AnituaE. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. Int. J. Oral Maxillofac. Implants14, 529–535 (1999).
   PubMed Web of Science ®Google Scholar
• AgrawalAA. Evolution, current status and advances in application of platelet concentrate in periodontics and implantology. World. J. Clin. Cases5(5), 159–171 (2017).
   PubMed Web of Science ®Google Scholar
• MurrayPE. Platelet-rich plasma and platelet-rich fibrin can induce apical closure more frequently than blood-clot revascularization for the regeneration of immature permanent teeth: a meta-analysis of clinical efficacy. Front. Bioeng. Biotechnol.6, 139 (2018).
   PubMed Web of Science ®Google Scholar
• XuJ , GouL , ZhangPet al.Platelet-rich plasma and regenerative dentistry. Aust. Dent. J.65(2), 131–142 (2020).
   PubMed Web of Science ®Google Scholar
• AttiaS , NarberhausC , SchaafHet al.Long-term influence of platelet-rich plasma (PRP) on dental implants after maxillary augmentation: retrospective clinical and radiological outcomes of a randomized controlled clinical trial. J. Clin. Med.9(2), 355 (2020).
   PubMed Web of Science ®Google Scholar
• YangLC , HuSW , YanMet al.Antimicrobial activity of platelet-rich plasma and other plasma preparations against periodontal pathogens. J. Periodontol.86(2), 310–318 (2015).
   PubMed Web of Science ®Google Scholar
• ZhuW , ZhuX , HuangGTet al.Regeneration of dental pulp tissue in immature teeth with apical periodontitis using platelet-rich plasma and dental pulp cells. Int. Endod. J.46(10), 962–970 (2013).
   PubMed Web of Science ®Google Scholar
• DelCorso M , VervelleA , SimonpieriAet al.Current knowledge and perspectives for the use of platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) in oral and maxillofacial surgery part 1: periodontal and dentoalveolar surgery. Curr. Pharm. Biotechnol.13(7), 1207–1230 (2012).
   PubMed Web of Science ®Google Scholar
• MasukiH , OkuderaT , WatanebeTet al.Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF). Int. J. Implant. Dent.2(1), 19 (2016).
   PubMedGoogle Scholar
• FranchiniM , CrucianiM , MengoliCet al.The use of platelet-rich plasma in oral surgery: a systematic review and meta-analysis. Blood Transfus.17(5), 357–367 (2019).
   PubMed Web of Science ®Google Scholar
• FanY , PerezK , DymH. Clinical uses of platelet-rich fibrin in oral and maxillofacial surgery. Dent. Clin. North Am.64(2), 291–303 (2020).
   PubMedGoogle Scholar
• AlissaR , EspositoM , HornerKet al.The influence of platelet-rich plasma on the healing of extraction sockets: an explorative randomised clinical trial. Eur. J. Oral Implantol.3(2), 121–134 (2010).
   PubMed Web of Science ®Google Scholar
• OgundipeOK , UgbokoVI , OwotadeFJ. Can autologous platelet-rich plasma gel enhance healing after surgical extraction of mandibular third molars?J. Oral Maxillofac. Surg.69(9), 2305–2310 (2011).
   PubMed Web of Science ®Google Scholar
• RutkowskiJL , JohnsonDA , RadioNMet al.Platelet rich plasma to facilitate wound healing following tooth extraction. J. Oral Implantol.36(1), 11–23 (2010).
   PubMed Web of Science ®Google Scholar
• PrataapN , SunilPM , SudeepCBet al.Platelet-rich plasma and incidence of alveolar osteitis in high-risk patients undergoing extractions of mandibular molars: a case–control study. J. Pharm. Bioallied Sci.9(5), S173–S179 (2017).
   PubMedGoogle Scholar
• SanchezAR , SheridanPJ , KuppLI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int. J. Oral Maxillofac. Implants18, 93–103 (2003).
   PubMed Web of Science ®Google Scholar
• ScevolaS , NicolettiG , BrentaFet al.Allogenic platelet gel in the treatment of pressure sores: a pilot study. Int. Wound J.7(3), 184–190 (2010).
   PubMed Web of Science ®Google Scholar
• Vidán-EstévezJ , EscalanteF , EscribanoPet al.Uso de los factores de crecimiento derivados de las plaquetas en úlceras cutáneas y osteonecrosis mandibular secundarias: una terapia eficaz. Presented at: LV Congreso Nacional de la Sociedad Española de Hematología y Hemoterapia.Seville, Spain, 17–19 October, 2013.
   Google Scholar
• Vidán-EstévezJ , Sánchez-HerráezS , Escalante-BarrigónFet al.Healing of chronic wounds with platelet-derived growth factors from single donor platelet-rich plasma following one freeze–thaw cycle. a cross-sectional study. J. Clin. Med.10, 5762 (2021).
   PubMed Web of Science ®Google Scholar
• Seco-CalvoJ , Vidán-EstévezJ , Sánchez-HerráezS. Successful healing of non-healing surgical wound based on the release of platelet-derived growth factors from single donor allogeneic platelet-rich plasma with one freeze-thaw cycle: a case report after a 1-year follow-up. Transl. Med. Commun.7, 14 (2022).
   Google Scholar
• RuggieroSL , DodsonTB , AghalooTet al.American Association of Oral and Maxillofacial Surgeons’ position paper on medication-related osteonecrosis of the jaws – 2022 update. J. Oral Maxillofac. Surg.80(5), 920–943 (2022).
   PubMed Web of Science ®Google Scholar
• SchiodtM , OttoS , FedeleSet al.Workshop of European Task Force on medication-related osteonecrosis of the jaw – current challenges. Oral Dis.25(7), 1815–1821 (2019).
   PubMed Web of Science ®Google Scholar
• ValenteNA , ChatelainS , AlfonsiFet al.Medication-related osteonecrosis of the jaw: the use of leukocyte-platelet-rich fibrin as an adjunct in the treatment. J. Craniofac. Surg.30(4), 1095–1101 (2019).
   PubMed Web of Science ®Google Scholar
• RollasonV , LaverrièreA , MacDonaldLCet al.Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). Cochrane Database Syst. Rev.2, CD008455 (2016).
   PubMedGoogle Scholar
• deSouza Tolentino E , de CastroTF , MichellonFCet al.Adjuvant therapies in the management of medication-related osteonecrosis of the jaws: systematic review. Head Neck41(12), 4209–4228 (2019).
   PubMed Web of Science ®Google Scholar
• Barba-RecreoP , DelCastillo Pardo de Vera JL , Georgiev-HristovTet al.Adipose-derived stem cells and platelet-rich plasma for preventive treatment of bisphosphonate-related osteonecrosis of the jaw in a murine model. J. Craniomaxillofac. Surg.43(7), 1161–1168 (2015).
   PubMed Web of Science ®Google Scholar
• Alonso-RodriguezE , González-Martín-MoroJ , Cebrián-CarreteroJLet al.Bisphosphonate-related osteonecrosis. Application of adipose-derived stem cells in an experimental murine model. Med. Oral Patol. Oral Cir. Bucal.24(4), e529–e536 (2019).
   PubMed Web of Science ®Google Scholar
• Rodríguez-LozanoFJ , Oñate-SánchezR , Gonzálvez-GarcíaMet al.Allogeneic bone marrow mesenchymal stem cell transplantation in tooth extractions sites ameliorates the incidence of osteonecrotic jaw-like lesions in zoledronic acid-treated rats. J. Clin. Med.9(6), 1649 (2020).
   PubMed Web of Science ®Google Scholar
• CardosoCL , CurraC , CuriMMet al.Treatment of bisphosphonate-related osteonecrosis using platelet-rich plasma: microtomographic, microscopic, and immunohistochemical analyses. Braz. Oral Res.33, e050 (2019).
   PubMed Web of Science ®Google Scholar
• ToroLF , de Mello-NetoJM , SantosFFVDet al.Application of autologous platelet-rich plasma on tooth extraction site prevents occurence of medication-related osteonecrosis of the jaws in rats. Sci. Rep.9(1), 22 (2019).
   PubMedGoogle Scholar
• CovielloV , PelusoF , DehkharganiSZet al.Platelet-rich plasma improves wound healing in multiple myeloma bisphosphonate-associated osteonecrosis of the jaw patients. J. Biol. Regul. Homeost. Agents26(1), 151–155 (2012).
   PubMed Web of Science ®Google Scholar
• FortunatoL , BennardoF , BuffoneCet al.Is the application of platelet concentrates effective in the prevention and treatment of medication-related osteonecrosis of the jaw? A systematic review. J. Craniomaxillofac. Surg.48(3), 268–285 (2020).
   PubMed Web of Science ®Google Scholar
• StellerD , HerbstN , PriesRet al.Positive impact of platelet-rich plasma and platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid. Sci. Rep.9, 8310 (2019).
   PubMed Web of Science ®Google Scholar
• SzentpeteriS , SchmidtL , RestarLet al.The effect of platelet-rich fibrin membrane in surgical therapy of medication-related osteonecrosis of the jaw. J. Oral Maxillofac. Surg.78(5), 738–748 (2020).
   PubMedGoogle Scholar
• GiudiceA , BaroneS , BennardoF. Effect of platelet-rich fibrin in surgical treatment of medication-related osteonecrosis of the jaw. J. Oral Maxillofac. Surg.78(10), 1659 (2020).
   PubMed Web of Science ®Google Scholar
• MalufG , CaldasRJ , SilvaSantos PS. Use of leukocyte- and platelet-rich fibrin in the treatment of medication-related osteonecrosis of the jaws. J. Oral Maxillofac. Surg.76(1), 88–96 (2018).
   PubMed Web of Science ®Google Scholar